An ROR1 bi-specific T-cell engager provides effective targeting and cytotoxicity against a range of solid tumors

Satyen Harish Gohil, Solange Rosa Paredes-Moscosso, Micaela Harrasser, Marzia Vezzalini, Aldo Scarpa, Emma Morris, Andrew M. Davidoff, Claudio Sorio, Amit Chunilal Nathwani, Marco Della Peruta
  • OncoImmunology, May 2017, Taylor & Francis
  • DOI: 10.1080/2162402x.2017.1326437
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Marzia Vezzalini and Dr Claudio Sorio